AGN Share Price Performance
CA$0.045
-0.04 (-43.75%)
Price CA$0.045
Share Pricen/a
Algernon Health Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
AGN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Algernon Health Inc. Key Details
About AGN
- Founded
- 2015
- Employees
- n/a
- CEO
- WebsiteView website
Algernon Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Pharmaceuticals Inc. and changed its name to Algernon Health Inc. in October 2025. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.
